READ THE LATEST

Catch up what you missed in longevity news, anti-aging research, and the fast-growing world of biohacking.

•

Sep 7, 2026

•

Aging Is a Cleanup Problem

SIRT1 - the most studied longevity protein - turns out to be the main guard against DNA jumping genes that destabilize the genome with age. Plus: a new analysis maps where longevity money actually goes (spoiler: not where you'd expect), and Alzheimer's leaves marks 7 years before plaques appear.

6 min read

•

Aug 31, 2026

•

🔍 Undercover In Longevity Clinics

FT journalists posed as patients at longevity clinics selling unproven stem cell therapies. What they found is alarming. Plus: Yale scientists may have found a shortcut to calorie restriction's anti-aging benefits - no starvation required.

9 min read

•

Aug 22, 2026

•

🏃‍➡️ The Molecular Case for Cardio

A new study shows cardiorespiratory improvements directly slow down epigenetic aging at the molecular level. Plus: the FDA's Alzheimer's drug decision is Monday, great progress in repairing damaged hearts, and the A-team of longevity scientists come together in one virtual room you can join.

7 min read

For Decades We Were Told to Avoid Full-Fat Dairy. New Research Disagrees 🧈

•

Aug 15, 2026

•

For Decades We Were Told to Avoid Full-Fat Dairy. New Research Disagrees 🧈

A 12-week study found three daily servings of full-fat dairy didn't worsen weight, cholesterol, or insulin resistance - and even improved blood pressure. Plus: a thymus hormone that reverses age-related inflammation in mice, and why Apple is racing to catch up with Whoop and Oura.

4 min read

•

Aug 9, 2026

•

Colombia, The Next Blue Zone? 🌎

A new biodemographic analysis found Colombian municipalities with centenarian rates rivaling Okinawa and Sardinia. Plus: a Cell paper argues we've been studying the wrong sex to understand aging, and everything you need to know about an environmental toxins test.

4 min read

•

Aug 2, 2026

•

FDA Loosens Restrictions On Peptides 💉

A key FDA panel voted to loosen restrictions on six peptides biohackers already use - over its own scientists' objections. Plus: a liver drug's real fibrosis-reversal data, and Wall Street's wild reaction to the peptide news.

4 min read

The Case for Treating Inflammation Like Cholesterol 🫀

•

Jul 26, 2026

•

The Case for Treating Inflammation Like Cholesterol 🫀

BioAge just dosed its first patient in a Phase 2 trial testing whether a daily pill can lower cardiovascular risk by targeting inflammation. Plus: Bryan Johnson's autoimmune diagnosis takes a strange turn, and a $100M bet on the future of longevity in the UAE.

7 min read

Ozempic Just Got a Lot More Interesting 💊

•

Jul 20, 2026

•

Ozempic Just Got a Lot More Interesting 💊

First clinical evidence that semaglutide may slow biological aging. Plus: FDA approves lecanemab for home self-injection, and the Mediterranean diet just got a new molecular explanation.

6 min read

•

Jul 13, 2026

•

100 And Counting

Scientists analyzed the blood of centenarians from the New England Centenarian Study and found a consistent set of metabolic patterns. Plus: the year's biggest Alzheimer's data event opens today in London.

7 min read

READ THE LATEST

Aging Is a Cleanup Problem

🔍 Undercover In Longevity Clinics

🏃‍➡️ The Molecular Case for Cardio

For Decades We Were Told to Avoid Full-Fat Dairy. New Research Disagrees 🧈

Colombia, The Next Blue Zone? 🌎

FDA Loosens Restrictions On Peptides 💉

The Case for Treating Inflammation Like Cholesterol 🫀

Ozempic Just Got a Lot More Interesting 💊

100 And Counting

Live longer. Live smarter.